Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids
2008

Proteomic Analysis for Detecting Chromosomal Abnormalities in Amniotic Fluid

Sample size: 52 publication Evidence: moderate

Author Information

Author(s): Mange Alain, Desmetz Caroline, Bellet Virginie, Molinari Nicolas, Maudelonde Thierry, Solassol Jerome

Primary Institution: University of Montpellier I, Montpellier, France

Hypothesis

Can a proteomic fingerprinting approach improve the diagnosis of aneuploidies in amniotic fluid samples?

Conclusion

The study shows that protein expression signatures can help identify potential biological markers for rapid clinical management of high-risk pregnancies.

Supporting Evidence

  • 40 protein peaks were significantly different between aneuploid and non-aneuploid samples.
  • Diagnostic accuracies were maintained at 87.5% and 91.67% in independent validation.
  • The study achieved a prediction accuracy of 92.3% and 96.43% using two class predictor models.

Takeaway

Scientists are using special tests to look at proteins in amniotic fluid to quickly find out if a baby might have certain chromosome problems.

Methodology

The study used mass spectrometry to analyze protein peaks in amniotic fluid samples from pregnant women.

Potential Biases

Potential contamination of samples with maternal cells could affect results.

Limitations

Some aneuploid samples were misclassified, and the study could not specify individual trisomy markers.

Participant Demographics

52 pregnant women undergoing amniocentesis for prenatal diagnosis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-5956-6-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication